DRG Attends AACC 2018 in Chicago!
DRG® International, Inc. Recently Showcased Newly Optimized Salivary Kits at AACC 2018!
DRG International, a leading international medical diagnostic company, showcased our Newly Optimized DRG® Saliva ELISA Assays at the 2018 AACC in Chicago, IL from July 30 – August 2, 2018. DRG® Optimized Saliva ELISA Assays are easy-to-use, non-invasive sampling test kits designed for the measurement of the free (unbound) fraction of steroids. These tests allow for simple, patient-friendly measurement of hormone profiles.
DRG® Optimized Saliva ELISAS include:
- FDA CLEARED TESTS
- Increased stability and linearity
- Ready to use reagents and user friendly assays
- Non-invasive, easy sampling particularly for babies and children
- Higher diagnostic relevance with reproducible and reliable results compared to serum analytics
- EXCELLENT CORRELATION TO MASS SPECTROMETRY
DRG® International, Inc., is committed to providing the medical and research community with cutting edge, easy-to-use and effective diagnostic equipment. DRG® International is constantly looking towards the future in order to continue to produce and distribute the highest-quality products.
You can buy our salivary ELISA kits at our Ecommerce store by clicking HERE.
News and Updates
The growth and further development of the North American market is a key priority for us and the sole focus of the new Sales and Business Development Executive we are looking to recruit.
On April 30th, 2020, an organized study by Radboud University Medical Center in Nijmegen, Netherlands, has completed a final report for the DRG International’s first ever Hepcidin Proficiency Test.
The Stifterverband für die Deutsche Wissenschaft honors the research activities of DRG Instruments GmbH with the “Innovative Through Research” seal of approval…